Correlation between Post-COVID-19, Chemosensitive Function, Blood Group, and Oral Health-Related Quality of Life

Table 5

Chi-square test of association between OHIP14 (oral health index profile) and chronic chemosensitive dysfunction in post-COVID-19 patients (fishers exact test).

Chemosensitive dysfunction	OHIP14		Chi-square	df	value
	Poor	Moderate
Subjective loss of smell
Anosmia	5 (62.5%)	3 (37.5%)	4.168	4	0.393^NS
Severe hyposmia	6 (42.9%)	8 (57.1%)
Moderate hyposmia	13 (46.4%)	15 (53.6%)
Mild hyposmia	9 (75.0%)	3 (25.0%)
Normal	23 (60.5%)	15 (39.5%)
Subjective loss of taste			6.624	4	0.157 NS
Ageusia	9 (64.3%)	6 (35.7%)
Severe hypogeusia	8 (53.3%)	7 (46.7%)
Moderate hypogeusia	11 (40.7%)	16 (59.3%)
Mild hypogeusia	10 (83.3%)	2 (16.7%)
Normal	18 (56.2%)	14 (43.8%)
CCCRC score			0.038	1	0.845 NS
Good	32 (55.2%)	26 (44.8%)
Poor	24 (57.1%)	18 (42.9%)
Taste intensity score			8.657	3	0.034
1	6 (31.6%)	13 (68.4%)
2	19 (51.4%)	18 (48.6%)
3	17 (70.8%)	7 (29.2%)
4	14 (70.0%)	6 (30.0%)
Dysgeusia			0.630	1	0.427 ^NS
No	48 (54.5%)	40 (45.5%)
Yes	8 (66.7%)	4 (33.3%)

NS: not significant () : significant ().